Kennedy Ferruggia, Associate Editor

The research narrows the most at-risk populations and how to mitigate the impacts on adults with ADRD.

Amivantamab-vmjw in combination with chemotherapy could assist patients diagnosed with non–small cell lung cancer when chemotherapy alone did not show benefit.

Individuals with age-related hearing loss should not be treated with “standard” hearing aids, but fitted to their personal needs, while avoiding settings that add distortion.

The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.

Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular lymphoma.

Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

Those infected with HIV could have experienced more hardships during the peak of the pandemic and could suffer more challenges with the lack of resources post-pandemic.

The use of psilocybin and psychedelic therapy can be a helpful tool for individuals with AUD and could have a positive outcome that can result in self compassion.

The blood pressure drug could provide relief for veterans and service members suffering from traumatic brain injuries.

To slow the production of MCI and dementia, utilizing more ways of establishing the diagnoses for women can prevent the progression.

The impact of smoke caused by Canadian wildfires raises concern for wildfire–related fine particles.

An expert panel discussed the outreach of social determinants of health in community pharmacy care and how pharmacists can help patients find and access resources.

Findings suggest that psychometric tests used for The Respiratory Infection Intensity and Impact Questionnaire provide reliable, construct validity, and responsive evidence to detect onset symptoms of RSV.

The findings suggest that the research conducted will be useful in enhancing the development of the HIV vaccine and can also be used to improve other viral pathogens.

Utilizing longitudinal assessments of language impairment and clinical progression could help identify challenges earlier.